Table A2:
Fraction of trimester opioid exposed on Neonatal Abstinence Syndrome (NAS)
Narrow NAS | Broad NAS | |||||
---|---|---|---|---|---|---|
|
||||||
Full sample | Sibling sample | Full sample | Sibling sample | |||
| ||||||
MAT-T1 | 0.177*** | 0.179*** | 0.104* | 0.288*** | 0.284*** | 0.158*** |
(0.037) | (0.050) | (0.061) | (0.039) | (0.053) | (0.060) | |
110.6% | 38.1% | 22.1% | 84.7% | 35.5% | 19.8% | |
MAT-T2 | 0.014 | 0.063 | 0.125 | 0.019 | 0.066 | 0.161* |
(0.059) | (0.077) | (0.096) | (0.062) | (0.082) | (0.096) | |
8.8% | 13.4% | 26.6% | 5.6% | 8.3% | 20.1% | |
MAT-T3 | 0.477*** | 0.408*** | 0.285*** | 0.506*** | 0.436*** | 0.275*** |
(0.042) | (0.055) | (0.069) | (0.043) | (0.056) | (0.068) | |
298.1% | 86.8% | 60.6% | 148.8% | 54.5% | 34.4% | |
non-MAT-T1 | 0.075*** | 0.068*** | 0.062*** | 0.113*** | 0.108*** | 0.098*** |
(0.012) | (0.016) | (0.019) | (0.014) | (0.019) | (0.023) | |
46.9% | 14.5% | 13.2% | 33.2% | 13.5% | 12.3% | |
non-MAT-T2 | 0.050*** | 0.068*** | 0.055** | 0.056*** | 0.067** | 0.042 |
(0.016) | (0.022) | (0.025) | (0.020) | (0.027) | (0.030) | |
31.3% | 14.5% | 11.7% | 16.5% | 8.4% | 5.3% | |
non-MAT-T3 | 0.118*** | 0.088*** | 0.029 | 0.203*** | 0.168*** | 0.111*** |
(0.013) | (0.018) | (0.021) | (0.017) | (0.023) | (0.027) | |
73.8% | 18.7% | 6.2% | 59.7% | 21.0% | 13.9% | |
Illicit-T1 | 0.206*** | 0.166*** | 0.084 | 0.315*** | 0.282*** | 0.143** |
(0.039) | (0.052) | (0.062) | (0.040) | (0.054) | (0.061) | |
128.8% | 35.3% | 17.9% | 92.6% | 35.3% | 17.9% | |
Illicit-T2 | 0.033 | 0.084 | 0.120 | 0.037 | 0.104 | 0.176* |
(0.062) | (0.081) | (0.099) | (0.063) | (0.083) | (0.098) | |
20.6% | 17.9% | 25.5% | 10.9% | 13.0% | 22.0% | |
Illicit-T3 | 0.394*** | 0.392*** | 0.249*** | 0.374*** | 0.327*** | 0.193** |
(0.053) | (0.070) | (0.084) | (0.051) | (0.068) | (0.080) | |
246.3% | 83.4% | 53.0% | 110.0% | 40.9% | 24.1% | |
| ||||||
Year FE | YES | YES | YES | YES | YES | YES |
MFE | NO | NO | YES | NO | NO | YES |
N | 255,227 | 44,838 | 44,838 | 255,227 | 44,838 | 44,838 |